Letter/Comment

AHA letter requesting the Biden Administration exercise enforcement discretion with respect to compliance with the Centers for Medicare…

AHA letter that outlines initial policy priorities for Biden Administration first 100 days.

AHA comments on the Centers for Medicare & Medicaid Services’ proposed regulation related to Medicaid program financing and supplemental payments.

January 31, 2023 April Tabor Secretary Federal Trade Commission 600 Pennsylvania Avenue NW Suite CC-5610 (Annex C) Washington, DC 20580 Re: Notice of Proposed Rulemaking, Federal Trade Commission; Non-Compete Clause Rule; 88 Fed. Reg. 3482 (RIN: 3084-AB74) (January 19, 2023) Dear Ms. Tabor:

AHA comments on the CMS’ Request for Information on Essential Health Benefits (EHB).

AHA comments on the CMS' proposed Notice of Benefit and Payment Parameters for 2024.

AHA provides feedback to the Senate on the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act, and to support Congress’ continued efforts to transform health care through permanent telehealth reform.

AHA provides feedback on the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act, and to support Congress’ continued efforts to transform health care through permanent telehealth reform

AHA comments proposed revisions to the regulations governing the confidentiality of substance use disorder (SUD) records, commonly known as 42 CFR Part 2 (“Part 2”).

January 27, 2023 Emeka Egwim, PharmD, RPh LCDR U.S. Public Health Service Director Office of Pharmacy Affairs Health Resources and Services Administration 5600 Fishers Lane, 08W05A Rockville, MD 20857 RE: HRSA 340B Drug Pricing Program; Administrative Dispute Resolution Proposed Rule, HHS Docket…